Cargando…
Do Concomitant Systematic Biopsies Add to Fusion Targeted Biopsies in the Diagnosis and Management of Clinically Significant Prostate Cancer?
OBJECTIVE: Magnetic resonance imaging targeted biopsy clearly detects more clinically significant prostate cancer than systematic biopsy. Whether concomitant systematic biopsy adds to targeted biopsy in the detection of clinically significant prostate cancer remains uncertain. The primary outcome me...
Autores principales: | Thompson, Alice, Eguru, Venkat, Moosa, Sohail, Ng, Yeung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Association of Urology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346108/ https://www.ncbi.nlm.nih.gov/pubmed/37877866 http://dx.doi.org/10.5152/tud.2023.22221 |
Ejemplares similares
-
The role of MRI/TRUS fusion biopsy in the diagnosis of clinically
significant prostate cancer
por: Benelli, Andrea, et al.
Publicado: (2020) -
Effectiveness of Bi-Parametric MR/US Fusion Biopsy for Detecting Clinically Significant Prostate Cancer in Prostate Biopsy Naïve Men
por: Kim, Young Joo, et al.
Publicado: (2019) -
Step-by-Step: Fusion-guided prostate biopsy in the diagnosis and surveillance of prostate cancer
por: Nassiri, Nima, et al.
Publicado: (2019) -
The accuracy of prostate cancer diagnosis in biopsy-naive patients using combined magnetic resonance imaging and transrectal ultrasound fusion-targeted prostate biopsy
por: Uno, Hiromi, et al.
Publicado: (2021) -
Comparison of pain levels in fusion prostate biopsy and standard TRUS-Guided biopsy
por: Demirtaş, Abdullah, et al.
Publicado: (2020)